Clinical Trial Update: A Phase 2a Study of TPN-101 in Patients With Progressive Supranuclear Palsy (PSP) [Phase 2]

View source ↗

Summary

This document reports the completion status of a Phase 2a clinical trial evaluating TPN-101 in patients with Progressive Supranuclear Palsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Progressive Supranuclear Palsy

Drugs mentioned

• TPN-101

Snippet

Sponsor: Transposon Therapeutics, Inc. | Conditions: Progressive Supranuclear Palsy | Phase 2 | Status: COMPLETED